ArticleCureus2024
Aripiprazole Provoking Gambling Disorder in a Patient With Opioid Use Disorder: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aripiprazole is an atypical antipsychotic used to treat certain mood disorders, such as bipolar disorder or schizophrenia, or as an adjunct therapy for treatment-resistant depression. In 2016, the FDA reported compulsive behaviors or uncontrollable urges can be associated with aripiprazole use. We report a 37-year-old Caucasian female with a past medical history of unspecified depressive disorder and opioid use disorder, who was treated with aripiprazole (Abilify) and then experienced compulsive gambling resulting in a suicide attempt. The patient reported playing scratch-off lottery tickets since childhood; however, she reported an ability to gamble responsibly and infrequently until one month before the admission. The patient started aripiprazole 10 mg daily, as an adjunct therapy for unspecified depressive disorder, approximately one year before the admission. We discuss the possibility of aripiprazole use, in combination with previous poor impulse control, intensifying recreational gambling to a level of gambling disorder. Because of the severity of these side effects, prior to beginning this medication, prescribing practitioners should consider if their patients have a history of compulsive behaviors and inform them of the potential for decreased impulse control with its use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.